BACKGROUND: Structural magnetic resonance imaging (MRI) has been used to investigate the in vivo pathology of frontotemporal lobar degeneration. However, few neuroimaging studies have focused on white matter (WM) alterations in this disease. OBJECTIVES: To use volumetric MRI techniques to identify the patterns of WM atrophy in vivo in 2 clinical variants of frontotemporal lobar degeneration-frontotemporal dementia (FTD) and semantic dementia-and to compare the patterns of WM atrophy with those of gray matter (GM) atrophy in these diseases. DESIGN: Structural MRIs were obtained from patients with FTD (n = 12) and semantic dementia (n = 13) and in cognitively healthy age-matched controls (n = 24). Regional GM and WM were classified automatically from high-resolution T1-, T2-, and proton density-weighted MRIs with Expectation-Maximization Segmentation and compared between the groups using a multivariate analysis of covariance model that included age and WM lesion volumes as covariates. RESULTS: Patients with FTD had frontal WM atrophy and frontal, parietal, and temporal GM atrophy compared with controls, who had none. Patients with semantic dementia had temporal WM and GM atrophy and patients with FTD had frontal GM atrophy. Adding temporal WM volume to temporal GM volume significantly improved the discrimination between semantic dementia and FTD. CONCLUSIONS: These results show that patients with frontotemporal lobar degeneration who are in relatively early stages of the disease (Clinical Dementia Rating score, 1.0-1.2) have WM atrophy that largely parallels the pattern of GM atrophy typically associated with these disorders.
BACKGROUND: Structural magnetic resonance imaging (MRI) has been used to investigate the in vivo pathology of frontotemporal lobar degeneration. However, few neuroimaging studies have focused on white matter (WM) alterations in this disease. OBJECTIVES: To use volumetric MRI techniques to identify the patterns of WM atrophy in vivo in 2 clinical variants of frontotemporal lobar degeneration-frontotemporal dementia (FTD) and semantic dementia-and to compare the patterns of WM atrophy with those of gray matter (GM) atrophy in these diseases. DESIGN: Structural MRIs were obtained from patients with FTD (n = 12) and semantic dementia (n = 13) and in cognitively healthy age-matched controls (n = 24). Regional GM and WM were classified automatically from high-resolution T1-, T2-, and proton density-weighted MRIs with Expectation-Maximization Segmentation and compared between the groups using a multivariate analysis of covariance model that included age and WM lesion volumes as covariates. RESULTS:Patients with FTD had frontal WM atrophy and frontal, parietal, and temporal GM atrophy compared with controls, who had none. Patients with semantic dementia had temporal WM and GM atrophy and patients with FTD had frontal GM atrophy. Adding temporal WM volume to temporal GM volume significantly improved the discrimination between semantic dementia and FTD. CONCLUSIONS: These results show that patients with frontotemporal lobar degeneration who are in relatively early stages of the disease (Clinical Dementia Rating score, 1.0-1.2) have WM atrophy that largely parallels the pattern of GM atrophy typically associated with these disorders.
Authors: Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale Journal: Neuron Date: 2002-01-31 Impact factor: 17.173
Authors: Yulin Ge; Robert I Grossman; James S Babb; Marcie L Rabin; Lois J Mannon; Dennis L Kolson Journal: AJNR Am J Neuroradiol Date: 2002-09 Impact factor: 3.825
Authors: Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind Journal: Semin Neurol Date: 2017-12-05 Impact factor: 3.420
Authors: Jennifer S Yokoyama; Celeste M Karch; Chun C Fan; Luke W Bonham; Naomi Kouri; Owen A Ross; Rosa Rademakers; Jungsu Kim; Yunpeng Wang; Günter U Höglinger; Ulrich Müller; Raffaele Ferrari; John Hardy; Parastoo Momeni; Leo P Sugrue; Christopher P Hess; A James Barkovich; Adam L Boxer; William W Seeley; Gil D Rabinovici; Howard J Rosen; Bruce L Miller; Nicholas J Schmansky; Bruce Fischl; Bradley T Hyman; Dennis W Dickson; Gerard D Schellenberg; Ole A Andreassen; Anders M Dale; Rahul S Desikan Journal: Acta Neuropathol Date: 2017-03-07 Impact factor: 17.088
Authors: M C Tartaglia; Y Zhang; C Racine; V Laluz; J Neuhaus; L Chao; J Kramer; H Rosen; B Miller; M Weiner Journal: J Neurol Date: 2011-10-29 Impact factor: 4.849
Authors: Po H Lu; Grace J Lee; Jill Shapira; Elvira Jimenez; Michelle J Mather; Paul M Thompson; George Bartzokis; Mario F Mendez Journal: J Alzheimers Dis Date: 2014 Impact factor: 4.472
Authors: Federica Agosta; Roland G Henry; Raffaella Migliaccio; John Neuhaus; Bruce L Miller; Nina F Dronkers; Simona M Brambati; Massimo Filippi; Jennifer M Ogar; Stephen M Wilson; Maria Luisa Gorno-Tempini Journal: Brain Date: 2009-09-16 Impact factor: 13.501
Authors: Po H Lu; Mario F Mendez; Grace J Lee; Alex D Leow; Hyun-Woo Lee; Jill Shapira; Elvira Jimenez; Bradley B Boeve; Richard J Caselli; Neill R Graff-Radford; Clifford R Jack; Joel H Kramer; Bruce L Miller; George Bartzokis; Paul M Thompson; David S Knopman Journal: Dement Geriatr Cogn Disord Date: 2013-01-09 Impact factor: 2.959
Authors: L L Chao; S G Mueller; S T Buckley; K Peek; S Raptentsetseng; J Elman; K Yaffe; B L Miller; J H Kramer; C Madison; D Mungas; N Schuff; M W Weiner Journal: Neurobiol Aging Date: 2008-06-11 Impact factor: 4.673
Authors: Yu Zhang; Norbert Schuff; An-Tao Du; Howard J Rosen; Joel H Kramer; Maria Luisa Gorno-Tempini; Bruce L Miller; Michael W Weiner Journal: Brain Date: 2009-05-12 Impact factor: 13.501